Editor's choice for December 2015
Editor's choice for December 2015
Novel estrogen receptor-targeting agent represents ‘quantum leap’
ASH 2015: Latest in CLL
How can functional drug screening guide personalised cancer therapy?
Ibrutinib to treat elderly patients with chronic lymphocytic leukaemia
First targeted therapy for multiple myeloma effective against hard-to-treat disease
First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival
Promising new strategy for treating children with acute lymphocytic leukaemia
Comment: Classification system based on cytogenetics and treatment response identifies leukaemia patients with high-risk clinical features
Engineered cells to target multiple myeloma
Classification system based on cytogenetics and treatment response identifies leukaemia patients with high risk clinical features with outstanding outcomes
Cancer Core Europe: where did it come from and what is its future?